ItalyOverall Rank
Rank in SubField 1
Publications
Total Cites
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,057 out of 64,751 Researchers
Data For The Year: 2026
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 173,404 | 180,683 |
| Total Cites | 6,237 | 7,291 |
| H-index | 38 | 40 |
| Hm-index | 14 | 16 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 14 | 14 |
| Number of Single+First Authored Papers | 73 | 73 |
| Total Cites to Single+First Authored Papers | 2,004 | 2,239 |
| Number of Single+First+Last Authored Papers | 129 | 129 |
| Total Cites to Single+First+Last Authored Papers | 2,977 | 3,292 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,754 | 5,319 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.37 |
| Self-Citation Percentage |
14.46%
|
|
Overall Rank
Rank in SubField 1
Publications
Total Cites
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,010 out of 61,090 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 164,975 | 170,127 |
| Total Cites | 6,035 | 7,105 |
| H-index | 37 | 40 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 13 | 13 |
| Number of Single+First Authored Papers | 73 | 73 |
| Total Cites to Single+First Authored Papers | 1,933 | 2,167 |
| Number of Single+First+Last Authored Papers | 129 | 129 |
| Total Cites to Single+First+Last Authored Papers | 2,870 | 3,184 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,585 | 5,141 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.38 |
| Self-Citation Percentage |
15.06%
|
|
Overall Rank
Rank in SubField 1
Publications
Total Cites
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 962 out of 57,585 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 157,978 | 163,036 |
| Total Cites | 5,793 | 6,847 |
| H-index | 36 | 39 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 13 | 13 |
| Number of Single+First Authored Papers | 73 | 73 |
| Total Cites to Single+First Authored Papers | 1,860 | 2,092 |
| Number of Single+First+Last Authored Papers | 129 | 129 |
| Total Cites to Single+First+Last Authored Papers | 2,763 | 3,071 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,391 | 4,936 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.39 |
| Self-Citation Percentage |
15.39%
|
|
Overall Rank
Rank in SubField 1
Publications
Total Cites
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 929 out of 54,095 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 150,550 | 153,058 |
| Total Cites | 5,614 | 6,656 |
| H-index | 35 | 39 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 73 | 73 |
| Total Cites to Single+First Authored Papers | 1,817 | 2,048 |
| Number of Single+First+Last Authored Papers | 129 | 129 |
| Total Cites to Single+First+Last Authored Papers | 2,701 | 3,003 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,231 | 4,772 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.39 |
| Self-Citation Percentage |
15.66%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.